Evidence map›Paper›PMID 22076153›Full record

ArticlePloS one2011

Derivation, characterization, and stable transfection of induced pluripotent stem cells from Fischer344 rats.

Mikhail Liskovykh, Ilya Chuykin, Ashish Ranjan, Dina Safina, Elena Popova, Elena Tolkunova, Valentina Mosienko, Julia M Minina, Natalia S Zhdanova, John J Mullins and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Dual Mode of Mitochondrial ROS Action during Reprogramming to Pluripotency.International journal of molecular sciences · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mikhail LiskovykhInstitute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.
Ilya Chuykin
Ashish Ranjan
Dina Safina
Elena Popova
Elena Tolkunova
Valentina Mosienko
Julia M Minina
Natalia S Zhdanova
John J Mullins
Michael Bader
Natalia Alenina
Alexey Tomilin
Max Delbrück Center · DEInstitute of Cytology · RUInstitute of Cytology and Genetics · RUThe Queen's Medical Research Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The rat represents an important animal model that, in many respects, is superior to the mouse for dissecting behavioral, cardiovascular and other physiological pathologies relevant to humans. Derivation of induced pluripotent stem cells from rats (riPS) opens the opportunity for gene targeting in specific rat strains, as well as for the development of new protocols for the treatment of different degenerative diseases. Here, we report an improved lentivirus-based hit-and-run riPS derivation protocol that makes use of small inhibitors of MEK and GSK3. We demonstrate that the excision of proviruses does not affect either the karyotype or the differentiation ability of these cells. We show that the established riPS cells are readily amenable to genetic manipulations such as stable electroporation. Finally, we propose a genetic tool for an improvement of riPS cell quality in culture. These data may prompt iPS cell-based gene targeting in rat as well as the development of iPS cell-based therapies using disease models established in this species.

Indexed as

Alkaline PhosphataseAnimalsCell- and Tissue-Based TherapyCell DifferentiationCells, CulturedElectroporationEmbryo, MammalianEmbryonic Stem CellsEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesFemaleFibroblastsGene TargetingGenetic VectorsGlycogen Synthase Kinase 3Green Fluorescent ProteinsAlkaline Phosphataseenhanced green fluorescent proteinEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3Green Fluorescent ProteinsMitogen-Activated Protein Kinase Kinases

Identifiers

PMID22076153
PMCPMC3208629
OpenAlexW2116160907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.